Cui Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cui Zhao has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Chi Zhang
Department of Neurology, Affiliated Hospital of Chengde Medical University, Chengde, China
1 shared publication- Daoqiang Zhang
Nanjing University of Aeronautics and Astronautics
1 shared publication En-Hong Xing
Central Laboratory, Affiliated Hospital of Chengde Medical University, Chengde, China
1 shared publicationGuolin Ma
Department of Radiology, China-Japan Friendship Hospital, BeiJing, China
1 shared publicationHaojie Chen
State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China
1 shared publicationJian Cheng
School of Computer Science and Engineering, Beihang University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 13 May 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Functional system-specific brain aging across the Alzheimer’s disease continuum
Accelerated brain aging is implicated in Alzheimer’s disease (AD). However, the spatial heterogeneity of brain aging patterns across different functional systems along the AD continuum remains largely unexplored. We developed functional system-specific brain age models derived from structural magnetic resonance imaging in a healthy adult cohort (n = 22,672) and applied them to 1478 participants across the AD continuum. Using up to 6 years of retrospective longitudinal data before clinical AD conversion, we quantified predicted age differences (PADs) and their change rates, characterized heterogeneous brain aging trajectories, and examined their associations with AD biomarkers, cognitive performance, and clinical progression. Progressive mild cognitive impairment (MCI) individuals showed early PAD deviations in the default mode network and accelerated changes in attention and control networks. System-wise PAD dynamics mediated the effects of AD-related biomarkers on cognitive decline. Integrating PAD features can improve predictive accuracy of MCI-to-AD conversion (AUC = 0.95). Functional system-specific PADs can be sensitive biomarkers for early detection and monitoring of individualized AD risk.
- 13 May 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1)
Open AccessFunctional system-specific brain aging across the Alzheimer’s disease continuum
Accelerated brain aging is implicated in Alzheimer’s disease (AD). However, the spatial heterogeneity of brain aging patterns across different functional systems along the AD continuum remains largely unexplored. We developed functional system-specific brain age models derived from structural magnetic resonance imaging in a healthy adult cohort (n = 22,672) and applied them to 1478 participants across the AD continuum. Using up to 6 years of retrospective longitudinal data before clinical AD conversion, we quantified predicted age differences (PADs) and their change rates, characterized heterogeneous brain aging trajectories, and examined their associations with AD biomarkers, cognitive performance, and clinical progression. Progressive mild cognitive impairment (MCI) individuals showed early PAD deviations in the default mode network and accelerated changes in attention and control networks. System-wise PAD dynamics mediated the effects of AD-related biomarkers on cognitive decline. Integrating PAD features can improve predictive accuracy of MCI-to-AD conversion (AUC = 0.95). Functional system-specific PADs can be sensitive biomarkers for early detection and monitoring of individualized AD risk.
- Open Access
- 18 January 2024
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-7
Relationship between methylenetetrahydrofolate reductase C677T gene polymorphism and neutrophil gelatinase-associated lipocalin in early renal injury in H-type hypertension
Objective: To analyse the relationship between the polymorphisms of the H-type hypertensive methylenetetrahydrofolate reductase (MTHFR) C677T gene and neutrophil gelatinase-associated lipocalin (NGAL) in early kidney injury. Method: A total of 279 hospitalised patients with hypertension were selected and grouped according to their homocysteine (Hcy) level. If their blood Hcy level was ≥ 10 µmol/L they were assigned to the H-type hypertensive group, and if it was < 10 µmol/L they were assigned to the non-H-type hypertensive group. Blood lipid indexes, renal function indexes and blood glucose indexes were collected, and the differences between the two groups were compared. Furthermore, MTHFR C677T genotype distribution and allele frequency and Hcy level of MTHFR C677T genotype were compared, and logistic multiple regression analysis was conducted for the correlation of different genotypes of MTHFR C677T and the early kidney injury marker NGAL. Results: In the non-H-type hypertensive group, the levels of Hcy and NGAL, cystatin, blood urea nitrogen, serum creatinine, uric acid, serum β2-microglobulin and urinary microalbumin-to-creatinine ratio increased significantly, and the glomerular filtration rate level decreased significantly, when compared with the H-type hypertensive group, with statistical differences (p < 0.05). The H-type hypertensive group and the non-H-type hypertensive group had significant differences in the CC, CT and TT genotypes and allele frequencies at the MTHFR C677T locus. The MTHFR C677T gene mutation rate of the H-type hypertensive group was significantly higher than that of the non-H-type hypertensive group. The H-type hypertensive group had higher levels of the TT genotype and CT genotype Hcy. There was a statistical difference (p < 0.05). Conclusion: Methylenetetrahydrofolate reductase C677T polymorphism is correlated with the Hcy level, and its gene polymorphism will affect the Hcy level. Methylenetetrahydrofolate reductase C677T polymorphism has an interactive effect with NGAL. Screening NGAL and reducing Hcy levels are valuable methods for the prevention and treatment of early renal injury in patients with H-type hypertension and help improve the prognosis of patients and their quality of life.
- 18 January 2024
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 24 (1) , 1-7
Open AccessRelationship between methylenetetrahydrofolate reductase C677T gene polymorphism and neutrophil gelatinase-associated lipocalin in early renal injury in H-type hypertension
Objective: To analyse the relationship between the polymorphisms of the H-type hypertensive methylenetetrahydrofolate reductase (MTHFR) C677T gene and neutrophil gelatinase-associated lipocalin (NGAL) in early kidney injury. Method: A total of 279 hospitalised patients with hypertension were selected and grouped according to their homocysteine (Hcy) level. If their blood Hcy level was ≥ 10 µmol/L they were assigned to the H-type hypertensive group, and if it was < 10 µmol/L they were assigned to the non-H-type hypertensive group. Blood lipid indexes, renal function indexes and blood glucose indexes were collected, and the differences between the two groups were compared. Furthermore, MTHFR C677T genotype distribution and allele frequency and Hcy level of MTHFR C677T genotype were compared, and logistic multiple regression analysis was conducted for the correlation of different genotypes of MTHFR C677T and the early kidney injury marker NGAL. Results: In the non-H-type hypertensive group, the levels of Hcy and NGAL, cystatin, blood urea nitrogen, serum creatinine, uric acid, serum β2-microglobulin and urinary microalbumin-to-creatinine ratio increased significantly, and the glomerular filtration rate level decreased significantly, when compared with the H-type hypertensive group, with statistical differences (p < 0.05). The H-type hypertensive group and the non-H-type hypertensive group had significant differences in the CC, CT and TT genotypes and allele frequencies at the MTHFR C677T locus. The MTHFR C677T gene mutation rate of the H-type hypertensive group was significantly higher than that of the non-H-type hypertensive group. The H-type hypertensive group had higher levels of the TT genotype and CT genotype Hcy. There was a statistical difference (p < 0.05). Conclusion: Methylenetetrahydrofolate reductase C677T polymorphism is correlated with the Hcy level, and its gene polymorphism will affect the Hcy level. Methylenetetrahydrofolate reductase C677T polymorphism has an interactive effect with NGAL. Screening NGAL and reducing Hcy levels are valuable methods for the prevention and treatment of early renal injury in patients with H-type hypertension and help improve the prognosis of patients and their quality of life.